Speaker(s): 

Adriana Modesto, PharmD Candidate, Student- has nothing to disclose.

Moderator(s): 

Christopher J DeFrancesco PharmD, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Evaluate the initiation, selection, and monitoring of antiretroviral therapy (ART), considering clinical criteria and patient-specific factors.
2. Identify common and clinically significant drug-drug interactions between ART agents and other medications, including anticoagulants, psychotropics, and antimicrobials.
3. Recognize and anticipate adverse effects associated with commonly prescribed ART regimens.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christopher DeFrancesco PharmD, RPH, Anil Singh MD, Roop Parlapalli, MD, FHM, FACP, Mary Ellen Berry PA-C, and Carlena Miller CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None